Literature DB >> 499300

Pharmacokinetics of cephacetrile in patients undergoing haemodialysis.

A Dominguez-Gil, J M Lanao, J M Tabernero, J L Rodriguez Commes, S de Castro.   

Abstract

The pharmacokinetics of cephacetrile were studied after its administration as a single i.v. bolus injection of 15 mg/kg body weight to 11 patients with terminal renal inpairment undergoing haemodialysis for 6 h. A two-compartment kinetic model was used to describe the biphasic decrease in plasma concentration. The quantities of antibiotic in the central and peripheral compartments, and the amounts eliminated, were calculated for different times. During haemodialysis sessions, the average pharmacokinetic parameters of cephacetrile determined at the dialyser input were: a = 5.03 h-1, beta = 0.458 h-1, K12 = 2.337 h-1, K21 = 1.996 h-1 K13 = 1.154 h-1, Vc = 5.5081, Vp = 6.4481, Vdss = 11.9561. As a function of the pharmacokinetic parameters of cephacetrile, a regimen of multiple doses was established for patients with terminal renal impairment, which will guarantee safe and effective concentrations of the antibiotic.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 499300     DOI: 10.1007/bf00644966

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  2 in total

Review 1.  Pharmacokinetics and clinical use of cephalosporin antibiotics.

Authors:  C H Nightingale; D S Greene; R Quintiliani
Journal:  J Pharm Sci       Date:  1975-12       Impact factor: 3.534

2.  Serum half-lives and elimination rates of a new semi-synthetic cephalosporin, cephacetrile, in nephrectomized patients and in patients with impaired or normal renal function.

Authors:  F Reutter; N P Maurice
Journal:  Arzneimittelforschung       Date:  1974-09
  2 in total
  3 in total

1.  Pharmacokinetics of phosphomycin during haemofiltration.

Authors:  C Fernandez Lastra; E L Mariño; A Dominguez-Gil; J M Tabernero; J Grande Villoria
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

2.  Pharmacokinetics of cefoxitin during haemofiltration.

Authors:  M J Garcia; A Dominguez-Gil; J M Tabernero; M Diaz Molina
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Elimination of cefroxadine (CGP-9000) from patients undergoing dialysis.

Authors:  M J Nieto; J M Lanao; A Dominguez-Gil; J M Tabernero; J F Macias
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.